Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013693
Filing Date
2023-04-20
Accepted
2023-04-20 16:24:02
Documents
9
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A allk-def_14a-2023_proxy_.htm DEF 14A 1774099
2 GRAPHIC img14357157_0.jpg GRAPHIC 22482
3 GRAPHIC img14357157_1.jpg GRAPHIC 3558
4 GRAPHIC img14357157_2.jpg GRAPHIC 3558
5 GRAPHIC img14357157_3.jpg GRAPHIC 52121
6 GRAPHIC img14357157_4.jpg GRAPHIC 281768
7 GRAPHIC img14357157_5.jpg GRAPHIC 285794
8 GRAPHIC img14357157_6.jpg GRAPHIC 797691
9 GRAPHIC img14357157_7.jpg GRAPHIC 159205
  Complete submission text file 0000950170-23-013693.txt   3987064
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38582 | Film No.: 23833420
SIC: 2834 Pharmaceutical Preparations